Search results
Glaxo (GSK) Up 1.6% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Singapore Finance· 1 month agoIt has been about a month since the last earnings report for GSK (GSK). Shares have added about 1.6%...
40 Best Last-Minute Father's Day Gifts from the Forgetful Kid
Redbook via Yahoo Style Singapore· 4 weeks agoHere are 45 last-minute Father's Day gifts that'll arrive by Father's Day—from subscription to gift...
The 10 Most Expensive Subscription Box Services in 2024
GOBankingRates via Yahoo Singapore Finance· 2 months agoIn recent years, subscription box services have taken off -- and the industry is forecast to get...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks via Yahoo Singapore Finance· 2 months agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...
GSK Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Singapore Finance· 2 months agoWe expect GSK's specialty products like Arexvy, Cabenuva, Juluca, Dovato, Nucala, Trelegy Ellipta and Shingrix to drive first-quarter sales performance.
GSK Gears Up for Q2 Earnings: Will It Surpass Estimates?
Zacks via Yahoo Singapore Finance· 11 months agoWe expect GSK plc. GSK to beat expectations when it reports second-quarter 2023 results on Jul 26....
Jim Simons Bolsters Position in Innoviva Inc with Recent Acquisition
GuruFocus.com via Yahoo Singapore Finance· 5 months agoOverview of the Recent Portfolio Addition Renaissance Technologies, led by Jim Simons (Trades,...
Did Walmart forget Cyber Monday is over? This hand massager is still on sale for just $40
Yahoo Life Shopping· 7 months agoThe holidays are a lovely time of year, but the cold weather that comes with them can inflame...
Theravance Biopharma (TBPH) to Sell Trelegy Royalty Interests
Zacks via Yahoo Singapore Finance· 2 years agoTheravance Biopharma (TBPH) agrees to sell its Trelegy royalty interests to Royalty Pharma. The...
Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results
GuruFocus.com via Yahoo Singapore Finance· 4 months agoRevenue: Innoviva Inc (NASDAQ:INVA) reported a 35% year-over-year increase in net product revenues...